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The incidence of gestational breast cancer (GBC), also called breast cancer 
diagnosed during pregnancy, is rising. GBC presents unique challenges in 
clinical management to optimise outcomes for mothers and their babies. 
Aim 
To examine the perinatal outcomes of women with GBC to create an evidence-
base to assist health care providers in clinical management. The main 
objectives were: 
• to describe the incidence, management, and perinatal outcomes of 
women with GBC, 
• to investigate factors affecting their survival, 
• to explore the safety of options available to healthcare providers for 
diagnosing GBC, and 
• to describe the outcomes of babies exposed to GBC systemic treatment. 
Methods 
Four studies were conducted using population-based data sets. Studies 1 and 2 
utilised New South Wales (NSW) data to investigate all women with 
pregnancies that ended in live birth or stillbirth between 1 January 1994 and 31 
December 2013. Studies 3 and 4 utilised data from the Australasian Maternity 
Outcome Surveillance System GBC study collected in Australia and New 




• Studies 1 and 2: The annual incidence of GBC in NSW was 6.8/100,000 
women. Women with GBC were more likely to give birth by labour induction 
or pre-labour caesarean section (CS) than women with no cancer (adjusted 
odds ratio (AOR) 4.8, 95%CI: 2.96–7.79). Babies born to women with GBC 
were more likely to be preterm (AOR 12.93, 95%CI: 8.97–18.64) and low 
birthweight. Of 122 women identified with GBC, 19.7% died within five years 
of diagnosis. The mortality rate for women with stage 4 cancer at diagnosis 
was 1,446/10,000 person-years, which is higher than that for women with 
stages 2 and 3 (399/10,000 person-years) or stage 1 (222/10,000 person-
years).  
• Studies 3 and 4: 83% of women with GBC experienced a painless breast 
lump. Breast ultrasound was the first-line imaging modality in all women. 
Eighteen babies exposed to breast cancer systemic treatment during 
pregnancy were born. None had a congenital malformation or major 
neonatal morbidity .  
Conclusion 
There was a high rate of preterm birth among women with GBC. Most births 
followed induction of labour or pre-labour CS. The crude 5-year mortality 
observed for women with GBC was 19.7%, which is almost double that 
previously reported for all women diagnosed with breast cancer in Australia. 
GBC diagnosed during mid-pregnancy and treated with chemotherapy was 
associated with a high rate of planned preterm birth but no increase in perinatal 
mortality.   
